Gain Therapeutics (GANX) Q4 2024 Earnings

Nov 14Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.45
-0.36
-0.26
-0.17

Details

Expected EPS
-0.20722
Actual EPS
-0.17
Surprise EPS
0.04
Surprise Percent
+17.96%

Description

⁨Gain Therapeutics⁩ (⁦GANX⁩) has reported earnings of ⁦-0.17⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts